Cite
Nattel S, Sager PT, Hüser J, et al. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovasc Res. 2021;117(7):1616-1631doi: 10.1093/cvr/cvab093.
Nattel, S., Sager, P. T., Hüser, J., Heijman, J., & Dobrev, D. (2021). Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovascular research, 117(7), 1616-1631. https://doi.org/10.1093/cvr/cvab093
Nattel, Stanley, et al. "Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it." Cardiovascular research vol. 117,7 (2021): 1616-1631. doi: https://doi.org/10.1093/cvr/cvab093
Nattel S, Sager PT, Hüser J, Heijman J, Dobrev D. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. Cardiovasc Res. 2021 Jun 16;117(7):1616-1631. doi: 10.1093/cvr/cvab093. PMID: 33769493; PMCID: PMC8208745.
Copy
Download .nbib